CA2572390A1 - Procedes spectroscopiques destines a une analyse d'une particule d'un composant - Google Patents
Procedes spectroscopiques destines a une analyse d'une particule d'un composant Download PDFInfo
- Publication number
- CA2572390A1 CA2572390A1 CA002572390A CA2572390A CA2572390A1 CA 2572390 A1 CA2572390 A1 CA 2572390A1 CA 002572390 A CA002572390 A CA 002572390A CA 2572390 A CA2572390 A CA 2572390A CA 2572390 A1 CA2572390 A1 CA 2572390A1
- Authority
- CA
- Canada
- Prior art keywords
- image
- sample
- particle
- substance
- raman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002245 particle Substances 0.000 title claims abstract description 261
- 238000004611 spectroscopical analysis Methods 0.000 title claims description 18
- 238000004458 analytical method Methods 0.000 title description 49
- 239000000126 substance Substances 0.000 claims abstract description 237
- 238000000034 method Methods 0.000 claims abstract description 200
- 239000000203 mixture Substances 0.000 claims abstract description 54
- 238000001069 Raman spectroscopy Methods 0.000 claims description 136
- 238000000701 chemical imaging Methods 0.000 claims description 71
- 230000003287 optical effect Effects 0.000 claims description 61
- 230000005855 radiation Effects 0.000 claims description 41
- 238000001228 spectrum Methods 0.000 claims description 32
- 238000012545 processing Methods 0.000 claims description 24
- 238000005286 illumination Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 13
- 230000001678 irradiating effect Effects 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 239000002952 polymeric resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920003002 synthetic resin Polymers 0.000 claims description 2
- 238000004566 IR spectroscopy Methods 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 1
- 238000000151 deposition Methods 0.000 claims 1
- 239000000693 micelle Substances 0.000 claims 1
- 238000003333 near-infrared imaging Methods 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 238000001429 visible spectrum Methods 0.000 claims 1
- 239000007762 w/o emulsion Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 64
- 238000009826 distribution Methods 0.000 abstract description 12
- 239000000523 sample Substances 0.000 description 217
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 74
- 229950000210 beclometasone dipropionate Drugs 0.000 description 58
- 230000003595 spectral effect Effects 0.000 description 57
- 238000003384 imaging method Methods 0.000 description 53
- 239000004973 liquid crystal related substance Substances 0.000 description 38
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 34
- 229940016286 microcrystalline cellulose Drugs 0.000 description 34
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 34
- 239000008108 microcrystalline cellulose Substances 0.000 description 34
- 229910052714 tellurium Inorganic materials 0.000 description 34
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 34
- 238000001237 Raman spectrum Methods 0.000 description 32
- QWUZMTJBRUASOW-UHFFFAOYSA-N cadmium tellanylidenezinc Chemical compound [Zn].[Cd].[Te] QWUZMTJBRUASOW-UHFFFAOYSA-N 0.000 description 32
- 230000000875 corresponding effect Effects 0.000 description 25
- 235000012431 wafers Nutrition 0.000 description 21
- 238000007792 addition Methods 0.000 description 20
- 239000004065 semiconductor Substances 0.000 description 20
- 238000001514 detection method Methods 0.000 description 19
- 239000003826 tablet Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000007922 nasal spray Substances 0.000 description 17
- 230000007547 defect Effects 0.000 description 15
- 238000001000 micrograph Methods 0.000 description 15
- 229940097496 nasal spray Drugs 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 14
- 239000008101 lactose Substances 0.000 description 14
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 13
- 229960001138 acetylsalicylic acid Drugs 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 239000012491 analyte Substances 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 239000011521 glass Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 238000013459 approach Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 238000012512 characterization method Methods 0.000 description 8
- 238000013480 data collection Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000010191 image analysis Methods 0.000 description 7
- 239000007791 liquid phase Substances 0.000 description 7
- 239000004005 microsphere Substances 0.000 description 7
- 229940068196 placebo Drugs 0.000 description 7
- 239000000902 placebo Substances 0.000 description 7
- 238000004445 quantitative analysis Methods 0.000 description 7
- 238000004497 NIR spectroscopy Methods 0.000 description 6
- 238000005054 agglomeration Methods 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 238000000399 optical microscopy Methods 0.000 description 6
- 230000010287 polarization Effects 0.000 description 6
- 238000002834 transmittance Methods 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 5
- KXNLCSXBJCPWGL-UHFFFAOYSA-N [Ga].[As].[In] Chemical compound [Ga].[As].[In] KXNLCSXBJCPWGL-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 238000007781 pre-processing Methods 0.000 description 5
- 238000004451 qualitative analysis Methods 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 238000003705 background correction Methods 0.000 description 4
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 4
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000012937 correction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000011496 digital image analysis Methods 0.000 description 4
- WPYVAWXEWQSOGY-UHFFFAOYSA-N indium antimonide Chemical compound [Sb]#[In] WPYVAWXEWQSOGY-UHFFFAOYSA-N 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000012634 optical imaging Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000000513 principal component analysis Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000010183 spectrum analysis Methods 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- -1 CdZnTe compound Chemical class 0.000 description 3
- 229910000661 Mercury cadmium telluride Inorganic materials 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 238000010219 correlation analysis Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 229940088679 drug related substance Drugs 0.000 description 3
- 238000001493 electron microscopy Methods 0.000 description 3
- 230000005251 gamma ray Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- ZXEYZECDXFPJRJ-UHFFFAOYSA-N $l^{3}-silane;platinum Chemical compound [SiH3].[Pt] ZXEYZECDXFPJRJ-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 238000003332 Raman imaging Methods 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000005284 basis set Methods 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000007621 cluster analysis Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000009021 linear effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 238000010238 partial least squares regression Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940067107 phenylethyl alcohol Drugs 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241001466538 Gymnogyps Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910021140 PdSi Inorganic materials 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 229910000577 Silicon-germanium Inorganic materials 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000006117 anti-reflective coating Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- MCMSPRNYOJJPIZ-UHFFFAOYSA-N cadmium;mercury;tellurium Chemical compound [Cd]=[Te]=[Hg] MCMSPRNYOJJPIZ-UHFFFAOYSA-N 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 238000001444 catalytic combustion detection Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000002575 chemical warfare agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000003331 infrared imaging Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000004476 mid-IR spectroscopy Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000011192 particle characterization Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910021339 platinum silicide Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000001055 reflectance spectroscopy Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000005393 sonoluminescence Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000012732 spatial analysis Methods 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000000904 thermoluminescence Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002235 transmission spectroscopy Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 229940006486 zinc cation Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3563—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing solids; Preparation of samples therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3577—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing liquids, e.g. polluted water
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1497—Particle shape
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Signal Processing (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58469604P | 2004-06-30 | 2004-06-30 | |
| US60/584,696 | 2004-06-30 | ||
| US10/882,082 US7046359B2 (en) | 2004-06-30 | 2004-06-30 | System and method for dynamic chemical imaging |
| US10/882,082 | 2004-06-30 | ||
| US11/000,778 | 2004-11-30 | ||
| US11/000,778 US7379179B2 (en) | 2004-06-30 | 2004-11-30 | Raman spectroscopic methods for component particle analysis |
| US11/091,126 US7595878B2 (en) | 2000-10-13 | 2005-03-28 | Spectroscopic methods for component particle analysis |
| US11/091,126 | 2005-03-28 | ||
| PCT/US2005/023635 WO2006091221A2 (fr) | 2004-06-30 | 2005-06-30 | Procedes spectroscopiques destines a une analyse d'une particule d'un composant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2572390A1 true CA2572390A1 (fr) | 2006-08-31 |
Family
ID=36927861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002572390A Abandoned CA2572390A1 (fr) | 2004-06-30 | 2005-06-30 | Procedes spectroscopiques destines a une analyse d'une particule d'un composant |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1766350A4 (fr) |
| CA (1) | CA2572390A1 (fr) |
| WO (1) | WO2006091221A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7993585B2 (en) | 2005-07-14 | 2011-08-09 | Battelle Memorial Institute | Biological and chemical monitoring |
| WO2007011726A1 (fr) | 2005-07-14 | 2007-01-25 | Battelle Memorial Institute | Dispositif de declenchement d'aerosol et procedes de detection de particules d'interet au moyen d'un dispositif de declenchement d'aerosol |
| US7554661B2 (en) * | 2005-09-19 | 2009-06-30 | Jmar Technologies, Inc. | Systems and methods for detection and classification of waterborne particles using a multiple angle light scattering (MALS) instrument |
| EP2827772B1 (fr) * | 2012-03-19 | 2023-10-04 | Genetic Innovations Inc. | Dispositifs, systèmes et procédés de coloration virtuelle |
| DE102013219181B4 (de) | 2013-09-24 | 2018-05-09 | Olympus Soft Imaging Solutions Gmbh | Vorrichtung und Verfahren zur optischen Bestimmung von Partikeleigenschaften |
| DE102015001033A1 (de) | 2015-01-27 | 2016-07-28 | Leibniz-Institut für Photonische Technologien e. V. | Hochdurchsatz-Screening-System zur Durchführung von optischen Messungen |
| EP3309537A1 (fr) * | 2016-10-14 | 2018-04-18 | Kaiser Optical Systems Inc. | Détermination de la taille de particules par spectroscopie raman |
| CN117783459B (zh) * | 2024-02-28 | 2024-05-07 | 沈阳科惠生物医药科技有限公司 | 一种药物的溶出曲线测定方法及系统 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3497690A (en) * | 1967-09-21 | 1970-02-24 | Bausch & Lomb | Method and apparatus for classifying biological cells by measuring the size and fluorescent response thereof |
| US7853411B2 (en) * | 1997-02-27 | 2010-12-14 | Cellomics, Inc. | System for cell-based screening |
| GB2326229A (en) * | 1997-06-13 | 1998-12-16 | Robert Jeffrey Geddes Carr | Detecting and analysing submicron particles |
| US6181414B1 (en) * | 1998-02-06 | 2001-01-30 | Morphometrix Technologies Inc | Infrared spectroscopy for medical imaging |
| CA2381344C (fr) * | 1999-08-05 | 2007-01-23 | Cellomics, Inc. | Analyse de cellules par systeme optique |
| AU2002361858A1 (en) * | 2001-12-21 | 2003-07-30 | Spectral Dimensions, Inc. | Spectrometric process monitoring |
| US7220592B2 (en) * | 2002-11-15 | 2007-05-22 | Eksigent Technologies, Llc | Particulate processing system |
-
2005
- 2005-06-30 EP EP05857501A patent/EP1766350A4/fr not_active Withdrawn
- 2005-06-30 CA CA002572390A patent/CA2572390A1/fr not_active Abandoned
- 2005-06-30 WO PCT/US2005/023635 patent/WO2006091221A2/fr active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| EP1766350A4 (fr) | 2010-01-20 |
| WO2006091221A3 (fr) | 2009-04-16 |
| WO2006091221A9 (fr) | 2007-02-01 |
| WO2006091221A2 (fr) | 2006-08-31 |
| EP1766350A2 (fr) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7595878B2 (en) | Spectroscopic methods for component particle analysis | |
| US6734962B2 (en) | Near infrared chemical imaging microscope | |
| Gendrin et al. | Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review | |
| CN101432606A (zh) | 用于组分颗粒分析的光谱方法 | |
| US6917423B2 (en) | Method for detection of pathogenic microorganisms | |
| US7564546B2 (en) | Dynamic imaging of biological cells and other subjects | |
| CA2572390A1 (fr) | Procedes spectroscopiques destines a une analyse d'une particule d'un composant | |
| US20060124443A1 (en) | Control and monitoring of non-resonant radiation-induced nucleation, crystallization, and polymorph formation | |
| US20130082180A1 (en) | Multipoint Method for Assessing a Biological Sample | |
| US7123358B2 (en) | Method for Raman imaging of semiconductor materials | |
| US7379179B2 (en) | Raman spectroscopic methods for component particle analysis | |
| US20070008525A1 (en) | Method for Raman imaging of semiconductor materials | |
| Lewis et al. | Near‐infrared spectral imaging with focal plane array detectors | |
| Pawluczyk et al. | Spectral imaging of microscopic samples with high-performance CCD array-based spectrometer | |
| Tambe et al. | Chemical Imaging: An overview and its Applications in Pharmaceutical Processes and Quality Control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |